×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 17: The FDA and Risk Management
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
- Pre-Marketing Risk Assessment
- Post-Marketing Risk Assessment
- Risk Evaluation and Mitigation Strategies (REMS)
Have an account?